Search Results - "Roncaglioni, Maria C."

Polypill Strategy in Secondary Cardiovascular Prevention by Castellano, Jose M., Pocock, Stuart J., Bhatt, Deepak L., Quesada, Antonio J., Owen, Ruth, Fernandez-Ortiz, Antonio, Sanchez, Pedro L., Marin Ortuño, Francisco, Vazquez Rodriguez, Jose M., Domingo-Fernández, Alexandra, Lozano, Iñigo, Roncaglioni, Maria C., Baviera, Marta, Foresta, Andreana, Ojeda-Fernandez, Luisa, Colivicchi, Furio, Di Fusco, Stefania A., Doehner, Wolfram, Meyer, Antje, Schiele, François, Ecarnot, Fiona, Linhart, Aleš, Lubanda, Jean-Claude, Barczi, Gyorgy, Merkely, Bela, Ponikowski, Piotr, Kasprzak, Marta, Fernandez Alvira, Juan M., Andres, Vicente, Bueno, Hector, Collier, Timothy, Van de Werf, Frans, Perel, Pablo, Rodriguez-Manero, Moises, Alonso Garcia, Angeles, Proietti, Marco, Schoos, Mikkel M., Simon, Tabassome, Fernandez Ferro, Jose, Lopez, Nicolas, Beghi, Ettore, Bejot, Yannick, Vivas, David, Cordero, Alberto, Ibañez, Borja, Fuster, Valentin

“…Among patients with recent MI, therapy with a polypill containing aspirin, ramipril, and atorvastatin led to a lower incidence of major adverse cardiovascular…”
Get full text

Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon‐like peptide‐1 receptor agonists or sodium‐glucose cotransporter‐2 inhibitors: A real‐world study in two Italian cohorts by Baviera, Marta, Genovese, Stefano, Lepore, Vito, Colacioppo, Pierluca, Robusto, Fabio, Tettamanti, Mauro, D'Ettorre, Antonio, Avanzini, Fausto, Fortino, Ida, Nicolucci, Antonio, Roncaglioni, Maria C., Giorgino, Francesco

“…Aim To examine the efficacy and safety of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and sodium‐glucose cotransporter‐2 (SGLT2) inhibitors compared…”
Get full text

Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-analysis of Randomized Controlled Trials by Berger, Jeffrey S, Roncaglioni, Maria C, Avanzini, Fausto, Pangrazzi, Ierta, Tognoni, Gianni, Brown, David L

“…CONTEXT Aspirin therapy reduces the risk of cardiovascular disease in adults who are at increased risk. However, it is unclear if women derive the same benefit…”
Get full text

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial by Sacco, Michele, Pellegrini, Fabio, Roncaglioni, Maria C, Avanzini, Fausto, Tognoni, Gianni, Nicolucci, Antonio

“…We investigated in general practice the efficacy of antiplatelets and antioxidants in primary prevention of cardiovascular events in people with type 2…”
Get full text

Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients by SACCO, Micheld, PHEGRINI, Fabio, RONCAGLIONI, Maria C, AVANZINI, Fausto, TOGNONI, Gianni, NICOLUCCI, Anionio

“…Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients Results of the Primary Prevention Project (PPP)…”
Get full text

Aspirin Resistance in Diabetic Patients by Sacco, Michele, Pellegrini, Fabio, Roncaglioni, Maria C., Avanzini, Fausto, Tognoni, Gianni, Nicolucci, Antonio

Get full text

Aspirin resistance in diabetic patients: response to de Gaetano by Sacco, Michele, Pellegrini, Fabio, Roncaglioni, Maria C, Avanzini, Fausto, Tognoni, Gianni, Nicolluci, Antonio

Get full text

Aspirin resistance in diabetic patients: response to Sacco et al by de Gaetano, Giovanni

Get full text

Defective ristocetin and bovine factor VIII-induced platelet aggregation in normal rats by de Gaetano, G, Donati, M B, Reyers-Degli Innocenti, I, Roncaglioni, M C

Get full text